2024-10-01 2025-08-31 false No description of principal activity Capium Accounts Production 1.1 14329836 2024-10-01 2025-08-31 14329836 bus:FullAccounts 2024-10-01 2025-08-31 14329836 bus:FRS102 2024-10-01 2025-08-31 14329836 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-08-31 14329836 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-08-31 14329836 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-08-31 14329836 2024-10-01 2025-08-31 14329836 2025-08-31 14329836 bus:RegisteredOffice 2024-10-01 2025-08-31 14329836 core:WithinOneYear 2025-08-31 14329836 core:AfterOneYear 2025-08-31 14329836 1 2024-10-01 2025-08-31 14329836 bus:Director1 2024-10-01 2025-08-31 14329836 bus:Director1 2025-08-31 14329836 bus:Director1 2023-10-01 2024-09-30 14329836 2023-10-01 14329836 bus:LeadAgentIfApplicable 2024-10-01 2025-08-31 14329836 2023-10-01 2024-09-30 14329836 2024-09-30 14329836 core:WithinOneYear 2024-09-30 14329836 core:AfterOneYear 2024-09-30 14329836 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 14329836 core:FurnitureFittings 2024-10-01 2025-08-31 14329836 core:FurnitureFittings 2025-08-31 14329836 core:FurnitureFittings 2024-09-30 14329836 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-08-31 14329836 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 14329836 core:NetGoodwill 2024-10-01 2025-08-31 14329836 core:NetGoodwill 2025-08-31 14329836 core:NetGoodwill 2024-09-30 14329836 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 14329836 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 14329836 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 14329836 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 14329836 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 14329836 core:Non-currentFinancialInstruments 2025-08-31 14329836 core:Non-currentFinancialInstruments 2024-09-30 14329836 core:ShareCapital 2025-08-31 14329836 core:ShareCapital 2024-09-30 14329836 core:RetainedEarningsAccumulatedLosses 2025-08-31 14329836 core:RetainedEarningsAccumulatedLosses 2024-09-30 14329836 dpl:Item1 2024-10-01 14329836 dpl:Item1 2025-08-31 14329836 dpl:Item1 2023-10-01 14329836 dpl:Item1 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 14329836
England and Wales
KR BANDA MEDCARE LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 October 2024 End date: 31 August 2025

KR BANDA MEDCARE LIMITED Contents Page For the Period 01 October 2024 to 31 August 2025
Company information | 1
Director's report | 2
Statement of financial position | 3
Notes to the financial statements | 4

KR BANDA MEDCARE LIMITED Company Information For the Period 01 October 2024 to 31 August 2025
Director | Kishore Reddy Banda
Registered Number | 14329836
Registered Office | 181 Hargate Way Hampton Hargate Peterborough PE7 8FL
1

KR BANDA MEDCARE LIMITED Director's Report For the Period 01 October 2024 to 31 August 2025
Director's report and financial statements The director presents their annual report and the financial statements for the year ended 31 August 2025 Director The director who served the company throughout the period was as follows:
Kishore Reddy Banda
On behalf of the board.
---------------------------------- Kishore Reddy Banda Director
Date approved: 27 January 2026 2

KR BANDA MEDCARE LIMITED Statement of Financial Position As at 31 August 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Intangible fixed assets | 3 | 843,131 |  | 885,870
Tangible fixed assets | 4 | 11,993 |  | 17,270
|  | 855,124 |  | 903,140
Current assets |  |  |
Stocks | 5 | 39,323 |  | 45,172
Debtors | 6 | 99,290 |  | 103,676
Cash at bank and in hand |  | 113,296 |  | 43,664
|  | 251,909 |  | 192,512
Creditors: amount falling due within one year | 7 | (338,647) |  | (350,460)
Net current assets |  | (86,738) |  | (157,948)
Total assets less current liabilities |  | 768,386 |  | 745,192
Creditors: amount falling due after more than one year | 8 | (788,086) |  | (817,730)
Net assets |  | (19,700) |  | (72,538)
Capital and reserves |  |  |
Called up share capital |  | 1 |  | 1
Profit and loss account |  | (19,701) |  | (72,539)
Shareholders' funds |  | (19,700) |  | (72,538)
For the period ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 27 January 2026 and were signed by:
------------------------------- Kishore Reddy Banda Director
3

KR BANDA MEDCARE LIMITED Notes to the Financial Statements For the Period 01 October 2024 to 31 August 2025
General Information KR BANDA MEDCARE LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14329836, registration address 181 Hargate Way, Hampton Hargate, Peterborough, PE7 8FL. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Intangible assets Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable. Goodwill Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 25% Straight Line
Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2. | Average number of employees Average number of employees during the period was 8 (2024 : 5).
3. | Intangible fixed assets
Cost | Goodwill |  | Total
| £ |  | £
At 01 October 2024 | 932,495 |  | 932,495
Additions | - |  | -
Disposals | - |  | -
At 31 August 2025 | 932,495 |  | 932,495
Amortisation
At 01 October 2024 | 46,625 |  | 46,625
Charge for period | 42,739 |  | 42,739
On disposals | - |  | -
At 31 August 2025 | 89,364 |  | 89,364
Net book values
At 31 August 2025 | 843,131 |  | 843,131
At 30 September 2024 | 885,870 |  | 885,870
4. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Total
| £ |  | £
At 01 October 2024 | 23,027 |  | 23,027
Additions | - |  | -
Disposals | - |  | -
At 31 August 2025 | 23,027 |  | 23,027
Depreciation
At 01 October 2024 | 5,757 |  | 5,757
Charge for period | 5,277 |  | 5,277
On disposals | - |  | -
At 31 August 2025 | 11,034 |  | 11,034
Net book values
Closing balance as at 31 August 2025 | 11,993 |  | 11,993
Opening balance as at 01 October 2024 | 17,270 |  | 17,270
5. | Stocks
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Stocks | 39,323 |  | 45,172
| 39,323 |  | 45,172
6. | Debtors: amounts falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Trade Debtors | 86,275 |  | 61,460
Prepayments & Accrued Income | 0 |  | 4,738
VAT | 13,015 |  | 37,478
| 99,290 |  | 103,676
7. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Trade Creditors | 163,458 |  | 144,921
Corporation Tax | 26,041 |  | 0
PAYE & Social Security | 501 |  | 453
Accrued Expenses | 48,772 |  | 1,000
Advance Paid | (1,454) |  | 0
Other Creditors | 28,501 |  | 30,500
Pension Payable | 198 |  | 96
Directors' Current Accounts | 72,630 |  | 173,490
| 338,647 |  | 350,460
8. | Creditors: amount falling due after more than one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Bank Loans & Overdrafts (secured) | 788,086 |  | 817,730
| 788,086 |  | 817,730
4